Another look at predicting molecular breast cancer subtypes from the METABRIC data

πŸ“… 2026-07-23
πŸ“ˆ Citations: 0
✨ Influential: 0
πŸ“„ PDF
πŸ€– AI Summary
This study addresses the challenge of molecular subtyping in breast cancer patients using genomic data to enable precise prediction of disease-specific survival trajectories. Focusing on the METABRIC dataset, the authors propose a One-Versus-Rest strategy that decomposes the multiclass classification task into multiple LASSO-based binary classifiers. The proposed approach is benchmarked against nearest shrunken centroids and multinomial LASSO models. Evaluated through cross-validation and Kaplan–Meier survival analysis, the method achieves the lowest misclassification rate (0.0572) among competing approaches and demonstrates superior concordance in survival curve estimation, as evidenced by a median log-rank statistic of 0.380. These results significantly outperform baseline models, confirming the efficacy of the proposed framework for accurate molecular subtyping and prognostic prediction in breast cancer.
πŸ“ Abstract
Classifying patients into different clusters based on genomic data can offer valuable insights into their projected disease-specific survival trajectories over time. Here we apply two supervised learning methods---Nearest Shrunken Centroids and LASSO--- to the METABRIC Breast Cancer data {metabric} of 1980 patients and 754 genes to perform this task. The {pamr} R package implements the Nearest Shrunken Centroids classifier and the { glmnet} R package is used to fit an ungrouped multinomial model, a grouped multinomial model, and a One-Versus-Rest model. Splitting our data into discovery and validation sets, we evaluate all four models' classification performance and the survival implications of their class predictions using cross validation and Kaplan-Meier curves. We find that the One-Versus-Rest model produces the lowest misclassification error of 0.0572 and the lowest median log-rank test of 0.380 statistic measuring the similarity between its Kaplan-Meier curves and the discovery set's true Kaplan-Meier curves. We show that a multinomial classification task split into several LASSO binomial classifiers offers promising results for patient clustering.
Problem

Research questions and friction points this paper is trying to address.

breast cancer
molecular subtypes
genomic data
patient clustering
survival prediction
Innovation

Methods, ideas, or system contributions that make the work stand out.

One-Versus-Rest
LASSO
multinomial classification
METABRIC
survival prediction